MedTrace Logo

Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula

NCT01573871 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2013-02-15

No results posted yet for this study

Summary

The objective of the study is to assess gastrointestinal tolerance and compliance in infants who require a hydrolyzed formula.

Conditions

  • Infant
  • Gastrointestinal Intolerance

Interventions

OTHER

Experimental Hydrolyzed infant formula

Experimental hydrolyzed infant formula to be fed ad libitum

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Marlene Borschel, PhD · Abbott Nutrition

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
180 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01573871 on ClinicalTrials.gov